July 18, 2012
A small observational study suggests that initiating immunotherapy early may improve seizure outcome in patients with medically intractable epilepsy for whom clinical and serological clues suggest an autoimmune basis. At an average of 17 months after these patients received immunotherapy, 81% reported improvements and 66% were seizure free.…
June 26, 2012
When compared with antiepileptic drug (AED) therapy alone, using respective surgery plus AED therapy appears to result in a lower probability of seizures after 2 years follow-up in patients with newly intractable, disabling mesial temporal lobe epilepsy. Results from a small study indicated that 73% of patients who received AED therapy plus surgery were seizure free at 2 years, compared with a 0% rate for patients who received only AED therapy.…
April 12, 2010
According to the Epilepsy Foundation of America, epilepsy is the third leading neurological disorder, affecting more than 3 million Americans, and more than 200,000 new cases are diagnosed each year. The estimated annual cost of epilepsy is $15.5 billion in direct and indirect costs.…
